Next Generation Sequencing (NGS) Product Market is expected to represent Significant CAGR of 15% by 2030 Major Players - Illumina , Thermo Fisher Scientific , BGI
Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco | Technology Networks
Illumina Remains NGS Leader But Competitors Expected to Gain, Survey Finds | GenomeWeb
Is Illumina Stock A Better Pick Over TMO?
How Low Can the Price of a Next Generation DNA Sequencer Go?
Thermo Fisher and Illumina Prepare for Round Two of the Next-Gen Sequencing Battle - Evolution Search Partners
Thermo Scientific MuSeek Index Set 1, Illumina compatible 24 dual indices | Fisher Scientific
Collibri™ Stranded RNA Library Prep Kit for Illumina™ Systems
Illumina (US) and Thermo Fisher Scientific (US) are the Major Players in the miRNA Sequencing and Assay Market
Thermo Fisher rumored to make $30B bid for Illumina | Fierce Biotech
Global Next Generation Sequencing (NGS) Market is expected to grow with the CAGR of 17.1% in the forecast period of 2022 to 2029. The years considered for study are as mentioned below.
Collibri™ ES DNA Library Prep Kits for Illumina Systems
Expanding Access to Ion AmpliSeq Technology - Behind the Bench
Next-Generation Sequencing (NGS) Market Worth Observing Growth: Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California - IPS Inter Press Service Business
A comparison of Illumina and Ion Torrent sequencing platforms in the context of differential gene expression | BMC Genomics | Full Text
Thermo Fisher Scientific, Illumina to Provide Broader Access to NGS Technology | Clinical Lab Products